63 related articles for article (PubMed ID: 1578374)
1. Acute administration of amphetamine: differential regulation of dopamine synthesis in dopamine projection fields.
Tyler CB; Galloway MP
J Pharmacol Exp Ther; 1992 May; 261(2):567-73. PubMed ID: 1578374
[TBL] [Abstract][Full Text] [Related]
2. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
Hu XT; White FJ
Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
[TBL] [Abstract][Full Text] [Related]
3. Regulation of dopamine and serotonin synthesis by acute administration of cocaine.
Galloway MP
Synapse; 1990; 6(1):63-72. PubMed ID: 2119072
[TBL] [Abstract][Full Text] [Related]
4. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
Compton DR; Johnson KM
J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468
[TBL] [Abstract][Full Text] [Related]
5. Blockade of D-1 dopamine receptors in the medial prefrontal cortex produces delayed effects on pre- and postsynaptic indices of dopamine function in the nucleus accumbens.
Vezina P; Blanc G; Glowinski J; Tassin JP
Synapse; 1994 Feb; 16(2):104-12. PubMed ID: 8197574
[TBL] [Abstract][Full Text] [Related]
6. Dopamine-dependent and dopamine-independent actions of cocaine as revealed by brain thermorecording in freely moving rats.
Kiyatkin EA; Brown PL
Eur J Neurosci; 2005 Aug; 22(4):930-8. PubMed ID: 16115216
[TBL] [Abstract][Full Text] [Related]
7. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
Millan MJ; Newman-Tancredi A; Brocco M; Gobert A; Lejeune F; Audinot V; Rivet JM; Schreiber R; Dekeyne A; Spedding M; Nicolas JP; Peglion JL
J Pharmacol Exp Ther; 1998 Oct; 287(1):167-86. PubMed ID: 9765336
[TBL] [Abstract][Full Text] [Related]
8. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.
Broening HW; Morford LL; Vorhees CV
Synapse; 2005 May; 56(2):84-93. PubMed ID: 15714503
[TBL] [Abstract][Full Text] [Related]
9. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
10. Dopamine and neurotensin storage in colocalized and noncolocalized neuronal populations.
Bean AJ; Adrian TE; Modlin IM; Roth RH
J Pharmacol Exp Ther; 1989 Jun; 249(3):681-7. PubMed ID: 2732943
[TBL] [Abstract][Full Text] [Related]
11. Comparative dopamine-cholinergic mechanisms in the olfactory tubercle and the striatum: effects of metoclopramide.
Suarez-Roca H; Lovenberg T; Cubeddu LX
J Pharmacol Exp Ther; 1987 Dec; 243(3):840-51. PubMed ID: 3320346
[TBL] [Abstract][Full Text] [Related]
12. Long-term reciprocal changes in dopamine levels in prefrontal cortex versus nucleus accumbens in rats born by Caesarean section compared to vaginal birth.
El-Khodor BF; Boksa P
Exp Neurol; 1997 May; 145(1):118-29. PubMed ID: 9184115
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic regulation of striatal acetylcholine release: importance of D1 and N-methyl-D-aspartate receptors.
Damsma G; Robertson GS; Tham CS; Fibiger HC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1064-72. PubMed ID: 1837058
[TBL] [Abstract][Full Text] [Related]
14. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
Burger LY; Martin-Iverson MT
Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985
[TBL] [Abstract][Full Text] [Related]
15. Medial prefrontal cortical D1 receptor modulation of the meso-accumbens dopamine response to stress: an electrochemical study in freely-behaving rats.
Doherty MD; Gratton A
Brain Res; 1996 Apr; 715(1-2):86-97. PubMed ID: 8739626
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of amphetamine transport vs. dopamine reverse transport on particulate PKC activity in striatal synaptoneurosomes.
Giambalvo CT
Synapse; 2003 Aug; 49(2):125-33. PubMed ID: 12740868
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological studies of the regulation of chronic FOS-related antigen induction by cocaine in the striatum and nucleus accumbens.
Nye HE; Hope BT; Kelz MB; Iadarola M; Nestler EJ
J Pharmacol Exp Ther; 1995 Dec; 275(3):1671-80. PubMed ID: 8531143
[TBL] [Abstract][Full Text] [Related]
18. Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine.
Altier N; Stewart J
J Pharmacol Exp Ther; 1998 Apr; 285(1):208-15. PubMed ID: 9536012
[TBL] [Abstract][Full Text] [Related]
19. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
Ichikawa J; Meltzer HY
J Pharmacol Exp Ther; 1999 Dec; 291(3):1227-32. PubMed ID: 10565846
[TBL] [Abstract][Full Text] [Related]
20. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
